Kader Thiam

Title: Kader Thiam: Innovator in Pharmaceutical Compositions

Introduction

Kader Thiam is a notable inventor based in Lille, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on lipopeptides. His research focuses on the development of new therapeutic agents that can enhance the efficacy of vaccines and medicines.

Latest Patents

Kader Thiam holds a patent for "Lipopeptides containing an interferon-γ fragment, and uses thereof in pharmaceutical compositions." This invention involves lipopeptides characterized by a peptide part that includes a sequence of approximately 30 to 50 contiguous amino acids from the C-terminal end of mammalian interferon-γ. The invention also encompasses lipopeptides that may contain various CD8, CD4, and B epitopes, as well as medicines or vaccines that utilize these polypeptides.

Career Highlights

Throughout his career, Kader Thiam has worked with various companies, including Genoway. His expertise in the pharmaceutical field has allowed him to contribute to advancements in drug development and vaccine formulation.

Collaborations

Kader Thiam has collaborated with notable colleagues such as Claude Auriault and Helene Gras-Masse. Their combined efforts have furthered research in the area of lipopeptides and their applications in medicine.

Conclusion

Kader Thiam's innovative work in the field of pharmaceuticals, particularly with lipopeptides, showcases his commitment to advancing medical science. His contributions are significant in the ongoing development of effective therapeutic agents.